SIMILAR PATTERNS OF AMINO ACIDS FOR 4URO_D_NOVD2000_1
List of similar pattern of amino acids derived from ASSAM searchHit | Macromolecule/ Organism |
Pfam | Res. | Interface | HETATM | RMSD | Dali Z-score | Seq. Identity (%) | View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1aj6 | GYRASE (Escherichiacoli) |
PF02518(HATPase_c) | 8 | ASN A 46GLU A 50ASP A 73ARG A 76ILE A 78PRO A 79ILE A 94THR A 165 | NOV A 1 (-4.0A)NOV A 1 (-3.8A)NOV A 1 (-3.5A)NOV A 1 (-3.5A)NOV A 1 (-4.1A)NOV A 1 (-4.2A)NOV A 1 ( 4.4A)NOV A 1 ( 4.1A) | 0.43A | 4uroD-1aj6A:28.9 | 4uroD-1aj6A:55.51 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1b63 | MUTL (Escherichiacoli) |
PF01119(DNA_mis_repair)PF13589(HATPase_c_3) | 6 | ASN A 33SER A 34ASP A 58ILE A 63ASP A 66THR A 143 | MG A 701 ( 2.5A)ANP A 380 ( 3.8A)ANP A 380 (-3.6A)ANP A 380 (-4.5A)NoneANP A 380 (-3.7A) | 0.85A | 4uroD-1b63A:14.9 | 4uroD-1b63A:22.61 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ekb | ENTEROPEPTIDASE (Bos taurus) |
PF00089(Trypsin) | 5 | ASN B 75SER B 74ASP B 153ILE B 80SER B 77 | None | 1.34A | 4uroD-1ekbB:undetectable | 4uroD-1ekbB:20.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1i5a | CHEMOTAXIS PROTEINCHEA (Thermotogamaritima) |
PF02518(HATPase_c) | 5 | ASN A 409ASP A 449ARG A 452ILE A 454THR A 531 | MN A 996 ( 2.8A)ACP A 998 (-3.7A)NoneACP A 998 (-4.3A)ACP A 998 (-3.8A) | 1.07A | 4uroD-1i5aA:5.5 | 4uroD-1i5aA:25.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1id0 | PHOQ HISTIDINEKINASE (Escherichiacoli) |
PF02518(HATPase_c) | 5 | ASN A 389ASP A 415ILE A 420PRO A 421ILE A 428 | ANP A 487 (-3.0A)ANP A 487 (-3.7A)ANP A 487 (-4.7A)NoneANP A 487 (-3.7A) | 0.77A | 4uroD-1id0A:6.0 | 4uroD-1id0A:23.16 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1kij | DNA GYRASE SUBUNIT B (Thermusthermophilus) |
PF00204(DNA_gyraseB)PF02518(HATPase_c) | 10 | ASN A 45GLU A 49ASP A 72ARG A 75ILE A 77PRO A 78ASP A 80ILE A 93ARG A 135THR A 166 | NOV A 400 (-3.8A)NOV A 400 (-3.6A)NOV A 400 (-3.1A)NOV A 400 (-3.4A)NOV A 400 (-4.1A)NOV A 400 (-4.4A)NOV A 400 (-2.8A)NOV A 400 (-4.5A)NOV A 400 (-2.7A)NOV A 400 (-3.3A) | 0.40A | 4uroD-1kijA:27.4 | 4uroD-1kijA:32.11 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1pe9 | PECTATE LYASE A (Dickeyachrysanthemi) |
PF00544(Pec_lyase_C) | 5 | ASP A 111ILE A 107ILE A 148SER A 193THR A 113 | None | 1.20A | 4uroD-1pe9A:undetectable | 4uroD-1pe9A:19.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1s14 | TOPOISOMERASE IVSUBUNIT B (Escherichiacoli) |
PF02518(HATPase_c) | 10 | ASN A1042SER A1043GLU A1046ASP A1069ARG A1072PRO A1075ASP A1077ILE A1090ARG A1132THR A1163 | NOV A1300 (-3.7A)NOV A1300 (-3.6A)NOV A1300 (-3.7A)NOV A1300 (-3.4A)NOV A1300 (-3.1A)NOV A1300 (-4.5A)NOV A1300 (-2.7A)NOV A1300 ( 4.6A)NOV A1300 (-2.9A)NOV A1300 ( 4.0A) | 0.50A | 4uroD-1s14A:25.1 | 4uroD-1s14A:37.34 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1s16 | TOPOISOMERASE IVSUBUNIT B (Escherichiacoli) |
PF00204(DNA_gyraseB)PF02518(HATPase_c) | 10 | ASN A1042SER A1043GLU A1046ASP A1069ARG A1072PRO A1075ASP A1077ILE A1090ARG A1132THR A1163 | ANP A1500 (-3.2A)ANP A1500 ( 4.0A)ANP A1500 (-3.7A)ANP A1500 (-3.5A)NoneNoneNoneANP A1500 ( 3.2A)NoneANP A1500 (-3.7A) | 0.73A | 4uroD-1s16A:25.2 | 4uroD-1s16A:30.47 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1tid | ANTI-SIGMA F FACTOR (Geobacillusstearothermophilus) |
PF13581(HATPase_c_2) | 5 | ASN A 50ASP A 81ILE A 86PRO A 87THR A 130 | ATP A 200 ( 2.8A)ATP A 200 (-4.0A)ATP A 200 (-4.2A)NoneATP A 200 (-3.4A) | 0.80A | 4uroD-1tidA:6.5 | 4uroD-1tidA:20.47 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1wac | P2 PROTEIN (Pseudomonasvirus phi6) |
PF00680(RdRP_1) | 5 | ASN A 638SER A 636ASP A 618ASP A 538SER A 604 | None | 1.35A | 4uroD-1wacA:undetectable | 4uroD-1wacA:16.34 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1z5a | TYPE II DNATOPOISOMERASE VISUBUNIT B (Sulfolobusshibatae) |
PF02518(HATPase_c)PF05833(FbpA)PF09239(Topo-VIb_trans) | 5 | ASN A 42SER A 43ASP A 76ILE A 81THR A 170 | MG A1001 ( 2.6A)ADP A2001 ( 3.9A)ADP A2001 (-3.7A)ADP A2001 (-4.5A)ADP A2001 ( 3.9A) | 0.58A | 4uroD-1z5aA:17.6 | 4uroD-1z5aA:18.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1z5a | TYPE II DNATOPOISOMERASE VISUBUNIT B (Sulfolobusshibatae) |
PF02518(HATPase_c)PF05833(FbpA)PF09239(Topo-VIb_trans) | 5 | SER A 43ASP A 76ILE A 81PRO A 82THR A 170 | ADP A2001 ( 3.9A)ADP A2001 (-3.7A)ADP A2001 (-4.5A)NoneADP A2001 ( 3.9A) | 0.76A | 4uroD-1z5aA:17.6 | 4uroD-1z5aA:18.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2afv | COBALAMINBIOSYNTHESISPRECORRIN ISOMERASE (Leptospirainterrogans) |
PF02570(CbiC) | 5 | SER A 176GLU A 150ARG A 154ILE A 149ILE A 123 | None | 1.25A | 4uroD-2afvA:undetectable | 4uroD-2afvA:23.42 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2d04 | CURCULIN (Molinerialatifolia) |
PF01453(B_lectin) | 5 | ASN B 30ILE B 25ILE B 64SER B 43THR B 24 | None | 1.13A | 4uroD-2d04B:undetectable | 4uroD-2d04B:21.82 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2lhs | CBP21 (Serratiamarcescens) |
PF03067(LPMO_10) | 5 | SER A 78ILE A 137PRO A 138ASP A 140ILE A 147 | None | 1.30A | 4uroD-2lhsA:undetectable | 4uroD-2lhsA:19.82 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2nn6 | POLYMYOSITIS/SCLERODERMA AUTOANTIGEN 1 (Homo sapiens) |
PF01138(RNase_PH)PF03725(RNase_PH_C) | 5 | GLU A 211ASP A 142ILE A 145ILE A 146THR A 53 | None | 1.38A | 4uroD-2nn6A:undetectable | 4uroD-2nn6A:19.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2pl1 | TRANSCRIPTIONALREGULATORY PROTEINPHOP (Escherichiacoli) |
PF00072(Response_reg) | 5 | GLU A 57ASP A 58ARG A 65ILE A 63ILE A 75 | None | 0.91A | 4uroD-2pl1A:undetectable | 4uroD-2pl1A:19.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2q6k | CHLORINASE (Salinisporatropica) |
PF01887(SAM_adeno_trans) | 5 | SER A 266ILE A 193PRO A 194ILE A 175ARG A 245 | None | 1.38A | 4uroD-2q6kA:undetectable | 4uroD-2q6kA:22.76 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2qv6 | GTP CYCLOHYDROLASEIII (Methanocaldococcusjannaschii) |
PF05165(GCH_III) | 5 | SER A 85GLU A 118ASP A 10ARG A 77ILE A 76 | None | 1.26A | 4uroD-2qv6A:undetectable | 4uroD-2qv6A:21.58 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2uzz | N-METHYL-L-TRYPTOPHAN OXIDASE (Escherichiacoli) |
PF01266(DAO) | 5 | GLU A 190ARG A 176ILE A 184ILE A 6THR A 186 | None | 1.35A | 4uroD-2uzzA:undetectable | 4uroD-2uzzA:20.22 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2x75 | ADENYLOSUCCINATELYASE (Staphylococcusaureus) |
PF00206(Lyase_1)PF10397(ADSL_C) | 5 | SER A 103GLU A 176ARG A 172ASP A 116ILE A 13 | None | 1.14A | 4uroD-2x75A:undetectable | 4uroD-2x75A:21.53 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2xvg | ALPHA XYLOSIDASE (Cellvibriojaponicus) |
PF01055(Glyco_hydro_31)PF16338(DUF4968)PF17137(DUF5110) | 5 | ASP A 782ILE A 905ILE A 923SER A 921THR A 778 | None | 1.24A | 4uroD-2xvgA:undetectable | 4uroD-2xvgA:12.25 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2zbk | TYPE 2 DNATOPOISOMERASE 6SUBUNIT B (Sulfolobusshibatae) |
PF02518(HATPase_c)PF09239(Topo-VIb_trans) | 5 | SER B 43ASP B 76ILE B 81PRO B 82THR B 170 | RDC B 531 (-3.2A)RDC B 531 (-2.9A)RDC B 531 (-4.3A)NoneRDC B 531 (-2.5A) | 0.87A | 4uroD-2zbkB:16.4 | 4uroD-2zbkB:18.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ag6 | PANTOTHENATESYNTHETASE (Staphylococcusaureus) |
PF02569(Pantoate_ligase) | 5 | SER A 264ILE A 261ILE A 257SER A 221ARG A 260 | None | 1.05A | 4uroD-3ag6A:undetectable | 4uroD-3ag6A:25.55 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3bt6 | INFLUENZA BHEMAGGLUTININ (HA) (Influenza Bvirus) |
PF00509(Hemagglutinin) | 5 | ASP A 64ILE A 97PRO A 96ILE A 243THR A 91 | None | 1.20A | 4uroD-3bt6A:undetectable | 4uroD-3bt6A:19.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3cg1 | UPF0100 PROTEINPF0080 (Pyrococcusfuriosus) |
PF13531(SBP_bac_11) | 5 | ASN A 137GLU A 143ILE A 144ASP A 149SER A 136 | None | 1.19A | 4uroD-3cg1A:undetectable | 4uroD-3cg1A:22.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3chx | PMOAPMOBPMOC (Methylosinustrichosporium) |
PF02461(AMO)PF04744(Monooxygenase_B)PF04896(AmoC) | 5 | ARG C 138ILE C 137ASP C 52ILE A 158THR B 196 | None | 1.30A | 4uroD-3chxC:undetectable | 4uroD-3chxC:21.01 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3dwk | PENICILLIN-BINDINGPROTEIN 2 (Staphylococcusaureus) |
PF00905(Transpeptidase)PF00912(Transgly) | 5 | ASN A 418SER A 446ASP A 449ILE A 673ILE A 676 | None | 1.32A | 4uroD-3dwkA:undetectable | 4uroD-3dwkA:17.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3fho | ATP-DEPENDENT RNAHELICASE DBP5 (Schizosaccharomycespombe) |
PF00270(DEAD)PF00271(Helicase_C) | 5 | GLU A 336ILE A 368ASP A 375ILE A 357ARG A 371 | None | 1.30A | 4uroD-3fhoA:undetectable | 4uroD-3fhoA:15.26 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3fv5 | DNA TOPOISOMERASE 4SUBUNIT B (Escherichiacoli) |
PF02518(HATPase_c) | 9 | ASN A 42SER A 43GLU A 46ASP A 69ARG A 72PRO A 75ILE A 90ARG A 132THR A 163 | 1EU A 2 (-4.9A)1EU A 2 (-3.0A)1EU A 2 (-3.4A)1EU A 2 (-3.3A)1EU A 2 (-3.3A)1EU A 2 (-4.2A)1EU A 2 (-4.5A)1EU A 2 (-3.9A)1EU A 2 (-3.7A) | 0.62A | 4uroD-3fv5A:27.8 | 4uroD-3fv5A:46.15 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3fv5 | DNA TOPOISOMERASE 4SUBUNIT B (Escherichiacoli) |
PF02518(HATPase_c) | 8 | SER A 43GLU A 46ASP A 69ARG A 72PRO A 75ASP A 77ARG A 132THR A 163 | 1EU A 2 (-3.0A)1EU A 2 (-3.4A)1EU A 2 (-3.3A)1EU A 2 (-3.3A)1EU A 2 (-4.2A)None1EU A 2 (-3.9A)1EU A 2 (-3.7A) | 0.97A | 4uroD-3fv5A:27.8 | 4uroD-3fv5A:46.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3fw8 | RETICULINE OXIDASE (Eschscholziacalifornica) |
PF01565(FAD_binding_4)PF08031(BBE) | 5 | SER A 141GLU A 140ARG A 127ILE A 198ILE A 206 | FAD A 1 (-3.1A)NoneNoneNoneNone | 1.36A | 4uroD-3fw8A:undetectable | 4uroD-3fw8A:18.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3h4l | DNA MISMATCH REPAIRPROTEIN PMS1 (Saccharomycescerevisiae) |
PF01119(DNA_mis_repair)PF13589(HATPase_c_3) | 5 | ASN A 65SER A 66ASP A 90ILE A 95THR A 174 | ANP A 397 ( 2.6A)ANP A 397 ( 4.0A)ANP A 397 (-3.6A)ANP A 397 (-4.4A)ANP A 397 (-3.7A) | 0.55A | 4uroD-3h4lA:16.9 | 4uroD-3h4lA:21.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3io1 | AMINOBENZOYL-GLUTAMATE UTILIZATIONPROTEIN (Klebsiellapneumoniae) |
PF01546(Peptidase_M20)PF07687(M20_dimer) | 5 | GLU A 413ASP A 412ILE A 209ILE A 156THR A 398 | None | 1.28A | 4uroD-3io1A:undetectable | 4uroD-3io1A:21.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3j2i | PROLIFERATION-ASSOCIATED PROTEIN 2G4 (Homo sapiens) |
PF00557(Peptidase_M24) | 5 | ASP A 97ARG A 281ILE A 80ILE A 108SER A 39 | None | 1.38A | 4uroD-3j2iA:undetectable | 4uroD-3j2iA:21.48 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3jsk | CYPBP37 PROTEIN (Neurosporacrassa) |
PF01946(Thi4) | 5 | ARG A 190ILE A 213ILE A 243SER A 257ARG A 212 | None | 1.12A | 4uroD-3jskA:undetectable | 4uroD-3jskA:21.74 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3l8d | METHYLTRANSFERASE (Bacillusthuringiensis) |
PF08241(Methyltransf_11) | 5 | SER A 108GLU A 138ARG A 141ILE A 139ILE A 120 | None | 1.28A | 4uroD-3l8dA:undetectable | 4uroD-3l8dA:21.17 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3l8d | METHYLTRANSFERASE (Bacillusthuringiensis) |
PF08241(Methyltransf_11) | 5 | SER A 108GLU A 138ARG A 141ILE A 139SER A 125 | None | 1.02A | 4uroD-3l8dA:undetectable | 4uroD-3l8dA:21.17 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3lpm | PUTATIVEMETHYLTRANSFERASE (Listeriamonocytogenes) |
PF05175(MTS) | 5 | ASN A 126ILE A 63PRO A 64ILE A 62THR A 124 | None | 1.26A | 4uroD-3lpmA:undetectable | 4uroD-3lpmA:23.16 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3lps | TOPOISOMERASE IVSUBUNIT B (Xanthomonasoryzae) |
PF00204(DNA_gyraseB)PF02518(HATPase_c) | 5 | ASN A 86ASP A 113ARG A 176ILE A 134THR A 207 | NOV A 901 (-4.0A)NOV A 901 (-3.5A)NOV A 901 (-2.5A)NOV A 901 ( 4.9A)NOV A 901 ( 4.2A) | 1.35A | 4uroD-3lpsA:27.1 | 4uroD-3lpsA:30.53 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3lps | TOPOISOMERASE IVSUBUNIT B (Xanthomonasoryzae) |
PF00204(DNA_gyraseB)PF02518(HATPase_c) | 10 | ASN A 86SER A 87GLU A 90ASP A 113ARG A 116PRO A 119ASP A 121ILE A 134ARG A 176THR A 207 | NOV A 901 (-4.0A)NOV A 901 (-3.3A)NOV A 901 (-3.8A)NOV A 901 (-3.5A)NOV A 901 (-3.4A)NOV A 901 (-4.5A)NOV A 901 (-2.6A)NOV A 901 ( 4.9A)NOV A 901 (-2.5A)NOV A 901 ( 4.2A) | 0.49A | 4uroD-3lpsA:27.1 | 4uroD-3lpsA:30.53 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3rko | NADH-QUINONEOXIDOREDUCTASESUBUNIT N (Escherichiacoli) |
no annotation | 5 | ASN N 285PRO N 228ASP N 229ILE N 303ARG N 296 | None | 1.35A | 4uroD-3rkoN:undetectable | 4uroD-3rkoN:17.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3sju | KETO REDUCTASE (Streptomycesgriseoruber) |
PF00106(adh_short) | 5 | GLU A 172ILE A 178ILE A 137ARG A 130THR A 176 | None | 1.39A | 4uroD-3sjuA:undetectable | 4uroD-3sjuA:23.65 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3u2k | DNA GYRASE SUBUNIT B (Staphylococcusaureus) |
PF02518(HATPase_c) | 11 | ASN A 54SER A 55GLU A 58ASP A 81ARG A 84ILE A 86PRO A 87ASP A 89ILE A 102ARG A 144THR A 173 | 087 A 1 (-3.9A)087 A 1 (-3.3A)087 A 1 (-3.4A)087 A 1 (-3.5A)087 A 1 (-3.8A)087 A 1 (-4.4A)087 A 1 (-4.3A)NoneNone087 A 1 (-2.5A)087 A 1 ( 3.8A) | 0.40A | 4uroD-3u2kA:31.3 | 4uroD-3u2kA:84.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3zkb | DNA GYRASE SUBUNIT B (Mycobacteriumtuberculosis) |
PF00204(DNA_gyraseB)PF02518(HATPase_c) | 7 | ASN A 52GLU A 56ASP A 79ARG A 82ILE A 84PRO A 85ARG A 141 | ANP A 601 ( 2.6A)ANP A 601 (-3.9A)ANP A 601 (-3.7A)NoneANP A 601 (-4.3A)NoneNone | 0.74A | 4uroD-3zkbA:28.4 | 4uroD-3zkbA:39.14 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4b6c | DNA GYRASE SUBUNIT B (Mycolicibacteriumsmegmatis) |
PF02518(HATPase_c) | 7 | ASN A 52GLU A 56ASP A 79ILE A 84PRO A 85ARG A 141THR A 169 | B5U A1256 (-3.2A)B5U A1256 (-3.6A)B5U A1256 (-3.5A)B5U A1256 (-4.3A)B5U A1256 (-4.2A)B5U A1256 ( 4.4A)B5U A1256 (-3.6A) | 0.57A | 4uroD-4b6cA:24.6 | 4uroD-4b6cA:48.48 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4b6c | DNA GYRASE SUBUNIT B (Mycolicibacteriumsmegmatis) |
PF02518(HATPase_c) | 7 | GLU A 56ASP A 79ARG A 82ILE A 84PRO A 85ARG A 141THR A 169 | B5U A1256 (-3.6A)B5U A1256 (-3.5A)B5U A1256 (-3.4A)B5U A1256 (-4.3A)B5U A1256 (-4.2A)B5U A1256 ( 4.4A)B5U A1256 (-3.6A) | 0.34A | 4uroD-4b6cA:24.6 | 4uroD-4b6cA:48.48 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4em7 | DNA TOPOISOMERASEIV, B SUBUNIT (Streptococcuspneumoniae) |
PF02518(HATPase_c) | 8 | ASN A 51GLU A 55ASP A 78ARG A 81ILE A 98SER A 124ARG A 140THR A 172 | 0RA A 301 (-4.7A)0RA A 301 (-3.4A)0RA A 301 (-3.6A)0RA A 301 ( 3.8A)NoneNone0RA A 301 (-2.5A)0RA A 301 ( 3.9A) | 0.67A | 4uroD-4em7A:29.4 | 4uroD-4em7A:53.85 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4em7 | DNA TOPOISOMERASEIV, B SUBUNIT (Streptococcuspneumoniae) |
PF02518(HATPase_c) | 8 | ASN A 51GLU A 55ASP A 78ARG A 81PRO A 84ILE A 98SER A 124THR A 172 | 0RA A 301 (-4.7A)0RA A 301 (-3.4A)0RA A 301 (-3.6A)0RA A 301 ( 3.8A)0RA A 301 ( 4.8A)NoneNone0RA A 301 ( 3.9A) | 0.73A | 4uroD-4em7A:29.4 | 4uroD-4em7A:53.85 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4hxe | PUTATIVEUNCHARACTERIZEDPROTEIN PH0594 (Pyrococcushorikoshii) |
PF00326(Peptidase_S9)PF07676(PD40) | 5 | ASN B 39SER B 38GLU B 37ASP B 7SER B 585 | None | 1.17A | 4uroD-4hxeB:undetectable | 4uroD-4hxeB:17.87 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4hxw | DNA GYRASE SUBUNIT B (Enterococcusfaecalis) |
PF02518(HATPase_c) | 9 | ASN A 55SER A 56GLU A 59ASP A 82ARG A 85ILE A 87PRO A 88SER A 129THR A 174 | 1A0 A 301 (-3.8A)1A0 A 301 (-3.3A)1A0 A 301 (-3.2A)1A0 A 301 (-3.4A)1A0 A 301 (-3.5A)1A0 A 301 (-3.9A)1A0 A 301 (-4.2A)1A0 A 301 (-3.2A)1A0 A 301 (-3.6A) | 0.53A | 4uroD-4hxwA:31.4 | 4uroD-4hxwA:65.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4hym | TOPOISOMERASE IV,SUBUNIT B (Francisellatularensis) |
PF00204(DNA_gyraseB)PF02518(HATPase_c) | 8 | ASN A 41SER A 42GLU A 45ASP A 68ARG A 71ILE A 89ARG A 131THR A 162 | CJC A 401 (-4.0A)CJC A 401 (-3.1A)CJC A 401 (-3.3A)CJC A 401 (-3.3A)CJC A 401 ( 4.0A)CJC A 401 (-4.6A)CJC A 401 (-4.2A)CJC A 401 (-3.6A) | 0.50A | 4uroD-4hymA:27.0 | 4uroD-4hymA:27.93 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4hym | TOPOISOMERASE IV,SUBUNIT B (Francisellatularensis) |
PF00204(DNA_gyraseB)PF02518(HATPase_c) | 8 | ASN A 41SER A 42GLU A 45ASP A 68ARG A 71PRO A 74ARG A 131THR A 162 | CJC A 401 (-4.0A)CJC A 401 (-3.1A)CJC A 401 (-3.3A)CJC A 401 (-3.3A)CJC A 401 ( 4.0A)CJC A 401 ( 4.7A)CJC A 401 (-4.2A)CJC A 401 (-3.6A) | 0.73A | 4uroD-4hymA:27.0 | 4uroD-4hymA:27.93 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4hym | TOPOISOMERASE IV,SUBUNIT B (Francisellatularensis) |
PF00204(DNA_gyraseB)PF02518(HATPase_c) | 7 | SER A 42GLU A 45ASP A 68ARG A 71ASP A 76ARG A 131THR A 162 | CJC A 401 (-3.1A)CJC A 401 (-3.3A)CJC A 401 (-3.3A)CJC A 401 ( 4.0A)NoneCJC A 401 (-4.2A)CJC A 401 (-3.6A) | 0.73A | 4uroD-4hymA:27.0 | 4uroD-4hymA:27.93 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4hz5 | DNA TOPOISOMERASEIV, B SUBUNIT (Enterococcusfaecalis) |
PF02518(HATPase_c) | 8 | ASN A 49GLU A 53ASP A 76ARG A 79PRO A 82ILE A 96ARG A 138THR A 169 | 19Y A 301 (-3.8A)19Y A 301 (-3.3A)19Y A 301 (-3.3A)19Y A 301 (-4.0A)19Y A 301 (-4.0A)19Y A 301 ( 4.7A)19Y A 301 ( 4.8A)19Y A 301 (-3.7A) | 0.54A | 4uroD-4hz5A:29.9 | 4uroD-4hz5A:54.08 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ja0 | PHOSPHORIBOSYLAMINOIMIDAZOLE CARBOXYLASE (Bombyx mori) |
PF00731(AIRC)PF01259(SAICAR_synt) | 5 | SER A 144GLU A 145ARG A 169ILE A 160THR A 131 | SO4 A 502 (-4.6A)SO4 A 502 (-4.3A)NoneNoneNone | 1.33A | 4uroD-4ja0A:undetectable | 4uroD-4ja0A:19.76 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4kc5 | RHIE PROTEIN (Paraburkholderiarhizoxinica) |
PF00109(ketoacyl-synt)PF02801(Ketoacyl-synt_C) | 5 | ASN A3182SER A3181ILE A3207PRO A3208SER A3141 | None | 1.14A | 4uroD-4kc5A:undetectable | 4uroD-4kc5A:13.23 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4mn8 | LRR RECEPTOR-LIKESERINE/THREONINE-PROTEIN KINASE FLS2 (Arabidopsisthaliana) |
PF00560(LRR_1)PF08263(LRRNT_2)PF13516(LRR_6)PF13855(LRR_8) | 5 | ASN A 489SER A 490ILE A 447PRO A 448ASP A 450 | NoneNoneNoneSO4 A 920 (-3.7A)None | 1.32A | 4uroD-4mn8A:undetectable | 4uroD-4mn8A:14.51 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4oe5 | DELTA-1-PYRROLINE-5-CARBOXYLATEDEHYDROGENASE,MITOCHONDRIAL (Homo sapiens) |
PF00171(Aldedh) | 5 | SER A 331GLU A 330ASP A 328ARG A 367ILE A 364 | None | 1.35A | 4uroD-4oe5A:undetectable | 4uroD-4oe5A:18.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4qts | CRISPR TYPEIII-ASSOCIATED RAMPPROTEIN CSM4 (Methanocaldococcusjannaschii) |
PF03787(RAMPs) | 5 | ASN A 31SER A 30ILE A 279PRO A 280ILE A 313 | None | 1.36A | 4uroD-4qtsA:undetectable | 4uroD-4qtsA:19.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4r39 | BLUE-LIGHT-ACTIVATEDHISTIDINE KINASE 2 (Erythrobacterlitoralis) |
PF07568(HisKA_2)PF13581(HATPase_c_2) | 5 | ARG A 285ILE A 287PRO A 288ASP A 290THR A 324 | NoneANP A 402 (-4.3A)ANP A 402 ( 4.4A)NoneANP A 402 (-3.6A) | 1.17A | 4uroD-4r39A:5.3 | 4uroD-4r39A:26.34 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4r39 | BLUE-LIGHT-ACTIVATEDHISTIDINE KINASE 2 (Erythrobacterlitoralis) |
PF07568(HisKA_2)PF13581(HATPase_c_2) | 5 | ASN A 250ARG A 285ILE A 287PRO A 288THR A 324 | MG A 401 ( 2.4A)NoneANP A 402 (-4.3A)ANP A 402 ( 4.4A)ANP A 402 (-3.6A) | 1.13A | 4uroD-4r39A:5.3 | 4uroD-4r39A:26.34 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4r39 | BLUE-LIGHT-ACTIVATEDHISTIDINE KINASE 2 (Erythrobacterlitoralis) |
PF07568(HisKA_2)PF13581(HATPase_c_2) | 5 | ASN A 250ASP A 282ILE A 287PRO A 288THR A 324 | MG A 401 ( 2.4A)ANP A 402 (-2.7A)ANP A 402 (-4.3A)ANP A 402 ( 4.4A)ANP A 402 (-3.6A) | 0.90A | 4uroD-4r39A:5.3 | 4uroD-4r39A:26.34 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4r39 | BLUE-LIGHT-ACTIVATEDHISTIDINE KINASE 2 (Erythrobacterlitoralis) |
PF07568(HisKA_2)PF13581(HATPase_c_2) | 5 | ASP A 282ILE A 287PRO A 288ASP A 290THR A 324 | ANP A 402 (-2.7A)ANP A 402 (-4.3A)ANP A 402 ( 4.4A)NoneANP A 402 (-3.6A) | 0.88A | 4uroD-4r39A:5.3 | 4uroD-4r39A:26.34 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4r3a | BLUE-LIGHT-ACTIVATEDHISTIDINE KINASE 2 (Erythrobacterlitoralis) |
PF07568(HisKA_2)PF13426(PAS_9)PF13581(HATPase_c_2) | 5 | ARG A 285ILE A 287PRO A 288ASP A 290THR A 324 | NoneANP A 401 (-4.3A)ANP A 401 ( 4.7A)NoneANP A 401 ( 4.1A) | 1.19A | 4uroD-4r3aA:4.1 | 4uroD-4r3aA:23.25 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4r3a | BLUE-LIGHT-ACTIVATEDHISTIDINE KINASE 2 (Erythrobacterlitoralis) |
PF07568(HisKA_2)PF13426(PAS_9)PF13581(HATPase_c_2) | 5 | ASN A 250ARG A 285ILE A 287PRO A 288THR A 324 | MG A 400 ( 2.5A)NoneANP A 401 (-4.3A)ANP A 401 ( 4.7A)ANP A 401 ( 4.1A) | 1.10A | 4uroD-4r3aA:4.1 | 4uroD-4r3aA:23.25 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4r3a | BLUE-LIGHT-ACTIVATEDHISTIDINE KINASE 2 (Erythrobacterlitoralis) |
PF07568(HisKA_2)PF13426(PAS_9)PF13581(HATPase_c_2) | 5 | ASN A 250ASP A 282ILE A 287PRO A 288THR A 324 | MG A 400 ( 2.5A)ANP A 401 (-3.3A)ANP A 401 (-4.3A)ANP A 401 ( 4.7A)ANP A 401 ( 4.1A) | 0.93A | 4uroD-4r3aA:4.1 | 4uroD-4r3aA:23.25 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4r3a | BLUE-LIGHT-ACTIVATEDHISTIDINE KINASE 2 (Erythrobacterlitoralis) |
PF07568(HisKA_2)PF13426(PAS_9)PF13581(HATPase_c_2) | 5 | ASP A 282ILE A 287PRO A 288ASP A 290THR A 324 | ANP A 401 (-3.3A)ANP A 401 (-4.3A)ANP A 401 ( 4.7A)NoneANP A 401 ( 4.1A) | 1.02A | 4uroD-4r3aA:4.1 | 4uroD-4r3aA:23.25 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4rgk | UNCHARACTERIZEDPROTEIN (Yersinia pestis) |
PF07350(DUF1479) | 5 | SER A 245ARG A 304ILE A 206ASP A 296ILE A 10 | None | 1.34A | 4uroD-4rgkA:undetectable | 4uroD-4rgkA:20.43 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4url | DNA TOPOISOMERASEIV, B SUBUNIT (Staphylococcusaureus) |
PF00204(DNA_gyraseB)PF02518(HATPase_c) | 8 | ASN A 49SER A 50GLU A 53ASP A 76ARG A 79ILE A 96ARG A 138THR A 168 | XAM A2000 (-3.9A)XAM A2000 (-3.4A)XAM A2000 (-3.1A)XAM A2000 (-3.6A)XAM A2000 (-3.7A)NoneNoneXAM A2000 (-3.6A) | 0.74A | 4uroD-4urlA:29.6 | 4uroD-4urlA:37.93 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4url | DNA TOPOISOMERASEIV, B SUBUNIT (Staphylococcusaureus) |
PF00204(DNA_gyraseB)PF02518(HATPase_c) | 8 | ASN A 49SER A 50GLU A 53ASP A 76ARG A 79PRO A 82ILE A 96THR A 168 | XAM A2000 (-3.9A)XAM A2000 (-3.4A)XAM A2000 (-3.1A)XAM A2000 (-3.6A)XAM A2000 (-3.7A)XAM A2000 (-4.8A)NoneXAM A2000 (-3.6A) | 0.64A | 4uroD-4urlA:29.6 | 4uroD-4urlA:37.93 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4urm | DNA GYRASE SUBUNIT B (Staphylococcusaureus) |
PF02518(HATPase_c) | 10 | ASN A 54SER A 55GLU A 58ASP A 81ARG A 84ILE A 86PRO A 87ASP A 89ARG A 144THR A 173 | XAM A2000 (-3.7A)XAM A2000 (-3.3A)XAM A2000 (-2.6A)XAM A2000 (-3.4A)XAM A2000 (-3.6A)XAM A2000 (-4.5A)XAM A2000 ( 4.9A)NoneNoneXAM A2000 (-3.8A) | 0.82A | 4uroD-4urmA:32.4 | 4uroD-4urmA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4urm | DNA GYRASE SUBUNIT B (Staphylococcusaureus) |
PF02518(HATPase_c) | 11 | ASN A 54SER A 55GLU A 58ASP A 81ARG A 84ILE A 86PRO A 87ILE A 102SER A 128ARG A 144THR A 173 | XAM A2000 (-3.7A)XAM A2000 (-3.3A)XAM A2000 (-2.6A)XAM A2000 (-3.4A)XAM A2000 (-3.6A)XAM A2000 (-4.5A)XAM A2000 ( 4.9A)XAM A2000 (-4.5A)XAM A2000 ( 4.4A)NoneXAM A2000 (-3.8A) | 0.49A | 4uroD-4urmA:32.4 | 4uroD-4urmA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4urn | DNA TOPOISOMERASEIV, B SUBUNIT (Staphylococcusaureus) |
PF02518(HATPase_c) | 9 | ASN A 49SER A 50GLU A 53ASP A 76ARG A 79PRO A 82ILE A 96ARG A 138THR A 168 | NOV A2000 (-3.8A)NOV A2000 ( 3.7A)NOV A2000 (-3.4A)NOV A2000 (-3.5A)NOV A2000 (-3.2A)NOV A2000 (-4.1A)NOV A2000 (-4.2A)NOV A2000 (-2.9A)NOV A2000 (-3.9A) | 0.62A | 4uroD-4urnA:29.9 | 4uroD-4urnA:58.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4xiv | CHEMOTAXIS PROTEINCHEA (Thermotogamaritima) |
PF02518(HATPase_c)PF02895(H-kinase_dim) | 5 | ASN A 409ASP A 449ARG A 452ILE A 454THR A 531 | ACP A 601 (-2.9A)ACP A 601 (-3.8A)NoneACP A 601 ( 4.6A)ACP A 601 (-3.9A) | 1.03A | 4uroD-4xivA:3.7 | 4uroD-4xivA:20.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4zoh | PUTATIVEOXIDOREDUCTASEMOLYBDOPTERIN-BINDING SUBUNIT (Sulfurisphaeratokodaii) |
PF01315(Ald_Xan_dh_C)PF02738(Ald_Xan_dh_C2) | 5 | SER A 382ASP A 381ILE A 412ILE A 308THR A 566 | None | 1.28A | 4uroD-4zohA:undetectable | 4uroD-4zohA:16.22 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4zpm | PROTEIN PCDHAC2 (Mus musculus) |
PF00028(Cadherin)PF08266(Cadherin_2) | 5 | SER A 44ILE A 63ASP A 101ILE A 96ARG A 62 | NoneNone CA A 804 ( 2.8A)NoneNone | 1.30A | 4uroD-4zpmA:undetectable | 4uroD-4zpmA:22.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4zvi | DNA GYRASE SUBUNIT B (Escherichiacoli) |
PF00204(DNA_gyraseB)PF02518(HATPase_c) | 9 | ASN A 46GLU A 50ASP A 73ARG A 76ILE A 78PRO A 79ILE A 94ARG A 136THR A 165 | 4S4 A 401 (-4.3A)4S4 A 401 (-3.1A)4S4 A 401 (-3.4A)4S4 A 401 (-2.8A)4S4 A 401 (-4.4A)4S4 A 401 (-4.5A)NoneNone4S4 A 401 ( 3.8A) | 0.44A | 4uroD-4zviA:30.0 | 4uroD-4zviA:57.69 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5b7i | CRISPR-ASSOCIATEDNUCLEASE/HELICASECAS3 SUBTYPEI-F/YPEST (Pseudomonasaeruginosa) |
no annotation | 5 | SER A 421ARG A 843ILE A 917PRO A 611ARG A 916 | None | 1.24A | 4uroD-5b7iA:undetectable | 4uroD-5b7iA:11.67 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ch6 | FRIGIDA (Vitis vinifera) |
PF07899(Frigida) | 5 | ASN A 252ARG A 217ILE A 246PRO A 247ASP A 210 | None | 1.20A | 4uroD-5ch6A:undetectable | 4uroD-5ch6A:18.73 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5czz | CRISPR-ASSOCIATEDENDONUCLEASE CAS9 (Staphylococcusaureus) |
PF13395(HNH_4)PF16592(Cas9_REC) | 5 | GLU A 628ARG A 630ILE A 632SER A 562THR A 587 | None | 1.32A | 4uroD-5czzA:undetectable | 4uroD-5czzA:12.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ew5 | COLICIN-E9 (Escherichiacoli) |
PF03515(Cloacin) | 5 | ASN A 236SER A 106ARG A 217PRO A 218SER A 238 | None | 1.32A | 4uroD-5ew5A:undetectable | 4uroD-5ew5A:16.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ghe | PESTICIDAL CRYSTALPROTEIN CRY6AA (Bacillusthuringiensis) |
no annotation | 5 | SER A 71ILE A 76PRO A 77ASP A 79ILE A 300 | None | 1.32A | 4uroD-5gheA:undetectable | 4uroD-5gheA:21.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5h71 | ALGQ2 (Sphingomonassp.) |
PF01547(SBP_bac_1) | 5 | GLU A 190ASP A 185ARG A 193SER A 273THR A 267 | NoneNoneNoneMAW A 501 ( 2.5A)None | 1.08A | 4uroD-5h71A:undetectable | 4uroD-5h71A:16.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5i5l | BACTERIOPHYTOCHROMEPROTEIN (Agrobacteriumfabrum) |
PF00360(PHY)PF01590(GAF)PF08446(PAS_2) | 5 | ILE A 224PRO A 223ILE A 31SER A 241ARG A 225 | None | 1.17A | 4uroD-5i5lA:undetectable | 4uroD-5i5lA:18.65 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5idm | CELL CYCLE HISTIDINEKINASE CCKA (Caulobactervibrioides) |
PF02518(HATPase_c) | 6 | ASN A 434ASP A 479ILE A 484PRO A 485ASP A 487ILE A 492 | MG A 602 ( 2.6A)ANP A 601 (-3.5A)ANP A 601 (-4.5A)NoneNoneANP A 601 ( 4.0A) | 1.20A | 4uroD-5idmA:6.3 | 4uroD-5idmA:22.04 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5j5p | DNA TOPOISOMERASE 4SUBUNIT B (Streptococcuspneumoniae) |
PF00204(DNA_gyraseB)PF02518(HATPase_c) | 6 | ASN A 51ASP A 78ARG A 140ILE A 98SER A 124THR A 172 | MG A 503 ( 2.5A)ANP A 501 (-2.6A)NoneANP A 501 ( 3.4A)ANP A 501 (-3.2A)ANP A 501 (-3.5A) | 1.43A | 4uroD-5j5pA:28.4 | 4uroD-5j5pA:40.18 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5j5p | DNA TOPOISOMERASE 4SUBUNIT B (Streptococcuspneumoniae) |
PF00204(DNA_gyraseB)PF02518(HATPase_c) | 9 | ASN A 51GLU A 55ASP A 78ARG A 81PRO A 84ILE A 98SER A 124ARG A 140THR A 172 | MG A 503 ( 2.5A)ANP A 501 (-3.2A)ANP A 501 (-2.6A)NoneNoneANP A 501 ( 3.4A)ANP A 501 (-3.2A)NoneANP A 501 (-3.5A) | 0.76A | 4uroD-5j5pA:28.4 | 4uroD-5j5pA:40.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5kuc | PESTICIDAL CRYSTALPROTEIN CRY6AA (Bacillusthuringiensis) |
no annotation | 5 | SER A 71ILE A 76PRO A 77ASP A 79ILE A 300 | None | 1.35A | 4uroD-5kucA:undetectable | 4uroD-5kucA:18.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5o6v | ENVELOPE PROTEIN (Tick-borneencephalitisvirus) |
no annotation | 5 | SER A 1ASP A 42ILE A 358SER A 321THR A 32 | None | 1.32A | 4uroD-5o6vA:undetectable | 4uroD-5o6vA:18.23 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5uhk | O-GLCNACASETIM-BARREL DOMAIN (Homo sapiens) |
PF07555(NAGidase) | 5 | ASN A 147SER A 146ASP A 184ILE A 143PRO A 139 | None | 1.38A | 4uroD-5uhkA:undetectable | 4uroD-5uhkA:21.49 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5uhp | O-GLCNACASETIM-BARREL DOMAIN (Homo sapiens) |
PF07555(NAGidase) | 5 | ASN A 147SER A 146ASP A 184ILE A 143PRO A 139 | None | 1.36A | 4uroD-5uhpA:undetectable | 4uroD-5uhpA:20.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5vvo | PROTEIN O-GLCNACASE (Homo sapiens) |
PF07555(NAGidase) | 5 | ASN A 147SER A 146ASP A 184ILE A 143PRO A 139 | None | 1.37A | 4uroD-5vvoA:undetectable | 4uroD-5vvoA:19.88 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ww1 | PULULLANASE (Paenibacillusbarengoltzii) |
no annotation | 5 | SER A 345ASP A 379ILE A 386ASP A 391ILE A 358 | None | 1.38A | 4uroD-5ww1A:undetectable | 4uroD-5ww1A:18.14 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5x9y | DNA MISMATCH REPAIRPROTEIN MUTL (Aquifexaeolicus) |
no annotation | 6 | ASN C 26SER C 27ASP C 51ILE C 56SER C 94THR C 135 | None | 1.18A | 4uroD-5x9yC:15.9 | 4uroD-5x9yC:23.51 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5xog | DNA-DIRECTED RNAPOLYMERASE SUBUNIT (Komagataellaphaffii) |
PF00623(RNA_pol_Rpb1_2)PF04983(RNA_pol_Rpb1_3)PF04990(RNA_pol_Rpb1_7)PF04992(RNA_pol_Rpb1_6)PF04997(RNA_pol_Rpb1_1)PF04998(RNA_pol_Rpb1_5)PF05000(RNA_pol_Rpb1_4) | 5 | ILE A 985PRO A 986ILE A 920SER A 908THR A1030 | None | 1.17A | 4uroD-5xogA:undetectable | 4uroD-5xogA:7.58 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6avg | T-CELL RECEPTORALPHA VARIABLE 4,TCRALPHA CHAIN (Homo sapiens) |
no annotation | 5 | SER C 64ILE C 67PRO C 68ASP C 70ILE C 36 | None | 0.97A | 4uroD-6avgC:undetectable | 4uroD-6avgC:15.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6bk7 | ELONGATION FACTOR G (Enterococcusfaecalis) |
no annotation | 5 | GLU A 91ASP A 87ILE A 90ILE A 400THR A 89 | None | 1.38A | 4uroD-6bk7A:undetectable | 4uroD-6bk7A:16.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6g72 | NADH-UBIQUINONEOXIDOREDUCTASE CHAIN2 (Mus musculus) |
no annotation | 5 | ASN N 197ILE N 265PRO N 262ILE N 344THR N 268 | None | 1.26A | 4uroD-6g72N:undetectable | 4uroD-6g72N:15.95 |